Antimalarial activity of sera from subjects taking HIV protease inhibitors

No abstract is available for this paper.

• Publication year

  2007

• Venue

  AIDS (London)

• Publication date

  2007-03-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/QAD.0b013e328031f41aPMID 17413699
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potencies of Human Immunodeficiency Virus Protease Inhibitors In Vitro against Plasmodium falciparum and In Vivo against Murine Malaria

  2006cited by this paper
• Antimalarial Activity of Human Immunodeficiency Virus Type 1 Protease Inhibitors

  2005cited by this paper
• HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa

  2004cited by this paper
• The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women

  2004cited by this paper
• Maternal Malaria and Perinatal HIV Transmission, Western Kenya,

  2004cited by this paper
• Antiretrovirals as antimalarial agents.

  2004cited by this paper
• The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda

  2003cited by this paper
• HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya

  2003cited by this paper
• Placental malaria and perinatal transmission of human immunodeficiency virus type 1.

  2003cited by this paper
• Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study.

  2000cited by this paper
• Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya.

  1998cited by this paper
• Potentiation of the antimalarial activity of atovaquone by doxycycline against Plasmodium falciparum in vitro

  1997cited by this paper
• Chloroquine bioassay using malaria microcultures.

  1993cited by this paper
• A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites.

  1993cited by this paper

• Signal peptide peptidase: a potential therapeutic target for parasitic and viral infections

  2022cites this paper
• Brief Report: No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor–Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297)

  2021cites this paper
• Repurposing Drugs to Fight Hepatic Malaria Parasites

  2020cites this paper
• Prevalence of malaria and clinical profile of febrile HIV infected patients in three HIV clinics in Ivory Coast

  2017cites this paper
• Inhibition of Plasmodium Hepatic Infection by Antiretroviral Compounds

  2017cites this paper
• Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children

  2016cites this paper
• Investigation of Novel Antimalarial Agents and Novel Target Identification Approaches

  2015cites this paper
• Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population

  2015cites this paper
• Neither the HIV Protease Inhibitor Lopinavir-Ritonavir nor the Antimicrobial Trimethoprim-Sulfamethoxazole Prevent Malaria Relapse in Plasmodium cynomolgi-Infected Non-Human Primates

  2014cites this paper
• Plasmodium falciparum gametocytes: with a view to a kill

  2013cites this paper
• Prevalence of asymptomatic parasitemia and gametocytemia among HIV-infected Ugandan children randomized to receive different antiretroviral therapies.

  2013cites this paper
• Activity of antiretroviral drugs in human infections by opportunistic agents

  2012cites this paper
• Saquinavir Inhibits the Malaria Parasite's Chloroquine Resistance Transporter

  2012cites this paper
• The Frequency of Malaria Is Similar among Women Receiving either Lopinavir/Ritonavir or Nevirapine-based Antiretroviral Treatment

  2012cites this paper
• Prevalence and clinical features of HIV and malaria co-infection in hospitalized adults in Beira, Mozambique

  2012cites this paper
• Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children.

  2012cites this paper
• In Vitro Activity of Antiretroviral Drugs against Plasmodium falciparum

  2011cites this paper
• Drugs for malaria: something old, something new, something borrowed

  2011cites this paper
• HIV-1 Protease Inhibitors and Clinical Malaria: a Secondary Analysis of the AIDS Clinical Trials Group A5208 Study

  2011cites this paper
• HIV proteinase inhibitors target the Ddi1-like protein of Leishmania parasites

  2011cites this paper
• Consequences of HIV infection on malaria and therapeutic implications: a systematic review.

  2011cites this paper
• Antimalarial Asexual Stage-Specific and Gametocytocidal Activities of HIV Protease Inhibitors (cid:1)

  2010cites this paper
• Challenges to the treatment of malaria

  2010influential citation
• Interactions between HIV infection and malaria in children living in sub-Saharan Africa in the era of widening access to improved interventions

  2010influential citation
• [Impact of malaria on HIV infection].

  2010cites this paper
• Impact du paludisme sur l’infection par le VIH

  2010cites this paper
• Evaluation of the effect of pyrimethamine, an anti-malarial drug, on HIV-1 replication.

  2010cites this paper
• Antimalarial Asexual Stage-Specific and Gametocytocidal Activities of HIV Protease Inhibitors

  2009cites this paper
• Plasmodium falciparum: new molecular targets with potential for antimalarial drug development

  2009cites this paper
• HIV protease inhibitors inhibit the development of preerythrocytic-stage plasmodium parasites.

  2009cites this paper
• HIV and malaria co-infection: interactions and consequences of chemotherapy.

  2008cites this paper
• Paludisme et infection par le VIH en Afrique subsaharienne

  2008cites this paper
• Stronger Activity of Human Immunodeficiency Virus Type 1 Protease Inhibitors against Clinical Isolates of Plasmodium vivax than against Those of P. falciparum

  2008cites this paper
• Prophylaxis and treatment of malaria in HIV-infected populations

  2008cites this paper
• HIV and malaria.

  2007cites this paper